# Biotech Daily Digest ‚Äî 2026-02-19

**35 items from 4 sources**

## Summary by Source

- Endpoints News: 8 items
- Fierce Biotech: 5 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 21 items


## Endpoints News

- **[Altesa raises $75M for oral respiratory med](https://endpoints.news/altesa-raises-75m-for-oral-respiratory-med/)**  
  _Thu, 19 Feb 2026 12:00:31 +0000_  
  Altesa BioSciences has closed a $75 million Series B, enough to finance a Phase 2b study of its oral respiratory drug meant to prevent serious COPD exacerbations.

 The raise announced Thursday adds fresh capital for ...

- **[J&J pauses patient recruitment in mid-stage trial of AC Immune‚Äôs Alzheimer‚Äôs drug](https://endpoints.news/jj-pauses-patient-recruitment-mid-stage-trial-of-ac-immunes-alzheimers-drug/)**  
  _Thu, 19 Feb 2026 11:55:09 +0000_  
  Johnson & Johnson has paused enrollment in the Phase 2b trial of its Alzheimer‚Äôs disease candidate, and the stock {$ACIU} of its partner AC Immune closed down about 10% on Wednesday.

 The asset is an ...

- **[Pharma is done negotiating as Trump pushes to codify deals](https://endpoints.news/pharma-is-done-negotiating-as-trump-pushes-to-codify-deals/)**  
  _Wed, 18 Feb 2026 20:00:26 +0000_  
  After Pfizer became the first drugmaker to voluntarily make pricing concessions to President Donald Trump, CEO Albert Bourla had to sell a skeptical board of industry peers on what exactly the benefit was.

 Bourla‚Äôs pitch ...

- **[J&J pours $1B into new cell therapy site in Pennsylvania](https://endpoints.news/jj-pours-1b-into-new-cell-therapy-site-in-pennsylvania/)**  
  _Wed, 18 Feb 2026 18:30:40 +0000_  
  Johnson & Johnson said it will spend more than $1 billion to build a cell therapy manufacturing plant in Pennsylvania as part of its broader commitment unveiled last year to invest more ...

- **[Charles River highlights increase in demand as tariff uncertainties fade](https://endpoints.news/charles-river-highlights-increase-in-demand-as-tariff-uncertainties-fade/)**  
  _Wed, 18 Feb 2026 17:33:30 +0000_  
  Charles River Laboratories said demand for its services is building back up after nearly a year of uncertainty around tariffs and drug pricing.



 With ‚Äútariff stuff being sort of over, and whatever pricing situations between ...

- **[Updated: Novartis signs macrocyclic deal with Unnatural Products](https://endpoints.news/novartis-signs-macrocyclic-deal-with-unnatural-products/)**  
  _Wed, 18 Feb 2026 15:45:20 +0000_  
  Novartis will pay $100 million in upfront and pre-IND milestone payments to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines.

 The move allows the ...

- **[Reversal on Moderna's flu application follows atypical path through FDA](https://endpoints.news/reversal-on-modernas-flu-application-follows-atypical-path-through-fda/)**  
  _Wed, 18 Feb 2026 15:45:05 +0000_  
  The decision by the FDA on Wednesday to reverse course and review Moderna's flu vaccine application was the result of a meeting Tuesday between an unusual group of senior FDA leaders and ...

- **[Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results](https://endpoints.news/lillys-zepbound-taltz-combo-data-in-psoriasis-and-weight-loss-novartis-bolsters-rhapsido-results/)**  
  _Wed, 18 Feb 2026 15:16:02 +0000_  
  ü§ù Lilly's Zepbound plus Taltz combo: The company said the drugs, when taken together, helped 27.1% of patients with plaque psoriasis and obesity (or who were overweight) achieve full skin clearance ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/study-finds-blood-test-can-predict-age-alzheimers-onset" hreflang="en">Study finds blood test can predict age of Alzheimer's onset</a>](https://www.fiercebiotech.com/medtech/study-finds-blood-test-can-predict-age-alzheimers-onset)**  
  _Feb 19, 2026 3:09am_  
  Newly FDA-cleared blood tests are now making it easier for doctors to diagnose Alzheimer‚Äôs disease. But could a single blood test also predict when symptoms will appear?

- **[<a href="https://www.fiercebiotech.com/research/gsk-strikes-5-year-deal-jackson-laboratory-focusing-neurogenerative-drug-development" hreflang="en">GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research</a>](https://www.fiercebiotech.com/research/gsk-strikes-5-year-deal-jackson-laboratory-focusing-neurogenerative-drug-development)**  
  _Feb 18, 2026 1:56pm_  
  Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory‚ÄìNew York Stem Cell Foundation to advance human cellular models of neurodegenerative diseases, according to a release.

- **[<a href="https://www.fiercebiotech.com/biotech/gut-focused-rasayana-therapeutics-ingests-gastrointestinal-candidate-36m-licensing-deal" hreflang="en">Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal</a>](https://www.fiercebiotech.com/biotech/gut-focused-rasayana-therapeutics-ingests-gastrointestinal-candidate-36m-licensing-deal)**  
  _Feb 18, 2026 10:26am_  
  In a deal with Theriva Biologics potentially worth as much as $36 million, Rasayana Therapeutics has gained a gastrointestinal asset called SYN-020.

- **[<a href="https://www.fiercebiotech.com/biotech/sensei-steps-back-brink-finding-faeth-and-its-phase-2-stage-cancer-drug" hreflang="en">Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug</a>](https://www.fiercebiotech.com/biotech/sensei-steps-back-brink-finding-faeth-and-its-phase-2-stage-cancer-drug)**  
  _Feb 18, 2026 10:03am_  
  Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. But the biotech has found a new lease on life‚Äîand a new lead drug‚Äîvia a merger with Faeth Therapeutics.

- **[<a href="https://www.fiercebiotech.com/biotech/novartis-finds-natural-partner-macrocycle-biotech-inking-17b-cardio-deal" hreflang="en">Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal </a>](https://www.fiercebiotech.com/biotech/novartis-finds-natural-partner-macrocycle-biotech-inking-17b-cardio-deal)**  
  _Feb 18, 2026 9:40am_  
  Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks.


## Regeneron Press Releases

- **[Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)](https://investor.regeneron.com/news-releases/news-release-details/garetosmab-biologics-license-application-accepted-fda-priority)**  
  _Thu, 19 Feb 2026 07:00:00 -0500_  
  FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability¬† If approved, garetosmab would be the first and only available treatment shown to reduce the number and


## arXiv q-bio

- **[Evolutionary Systems Thinking -- From Equilibrium Models to Open-Ended Adaptive Dynamics](https://arxiv.org/abs/2602.15957)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.15957v1 Announce Type: new 
Abstract: Complex change is often described as "evolutionary" in economics, policy, and technology, yet most system dynamics models remain constrained to fixed state spaces and equilibrium-seeking behavior. This paper argues that evolutionary dynamics should be treated as a core‚Ä¶

- **[Time-Varying Directed Interactions in Functional Brain Networks: Modeling and Validation](https://arxiv.org/abs/2602.16004)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16004v1 Announce Type: new 
Abstract: Understanding the dynamic nature of brain connectivity is critical for elucidating neural processing, behavior, and brain disorders. Traditional approaches such as sliding-window correlation (SWC) characterize time-varying undirected associations but do not resolve dire‚Ä¶

- **[Properties of biodiversity indices that model future extinction risk](https://arxiv.org/abs/2602.16059)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16059v1 Announce Type: new 
Abstract: The loss of biodiversity due to the likely widespread extinction of species in the near future is a focus of current concern in conservation biology. One approach to measure the impact of this extinction is based on the predicted loss of phylogenetic diversity. These pr‚Ä¶

- **[Piecewise integrability of the discrete Hasimoto map for analytic prediction and design of helical peptides](https://arxiv.org/abs/2602.16255)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16255v1 Announce Type: new 
Abstract: The representation of protein backbone geometry through the discrete nonlinear Schr\"odinger equation provides a theoretical connection between biological structure and integrable systems. Although the global application of this framework is constrained by chiral degene‚Ä¶

- **[Neutral species facilitate coexistence among cyclically competing species under birth and death processes](https://arxiv.org/abs/2602.16282)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16282v1 Announce Type: new 
Abstract: Natural birth and death are fundamental mechanisms of population dynamics in ecosystems and have played pivotal roles in shaping population dynamics. Nevertheless, in studies of cyclic competition systems governed by the rock-paper-scissors (RPS) game, these mechanisms‚Ä¶

- **[Evolutionary Advantage of Diversity-Generating Retroelements in Switching Environments](https://arxiv.org/abs/2602.16447)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16447v1 Announce Type: new 
Abstract: Diversity-Generating Retroelements (DGRs) create rapid, targeted variation within specific genomic regions in phages and bacteria. They operate through stochastic retro-transcription of a template region (TR) into a variable region (VR), which typically encodes ligand-b‚Ä¶

- **[GRIMM: Genetic stRatification for Inference in Molecular Modeling](https://arxiv.org/abs/2602.16504)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16504v1 Announce Type: new 
Abstract: The vast majority of biological sequences encode unknown functions and bear little resemblance to experimentally characterized proteins, limiting both our understanding of biology and our ability to harness functional potential for the bioeconomy. Predicting enzyme func‚Ä¶

- **[The Representational Alignment Hypothesis: Evidence for and Consequences of Invariant Semantic Structure Across Embedding Modalities](https://arxiv.org/abs/2602.16584)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16584v1 Announce Type: new 
Abstract: There is growing evidence that independently trained AI systems come to represent the world in the same way. In other words, independently trained embeddings from text, vision, audio, and neural signals share an underlying geometry. We call this the Representational Ali‚Ä¶

- **[Parameter-free representations outperform single-cell foundation models on downstream benchmarks](https://arxiv.org/abs/2602.16696)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16696v1 Announce Type: new 
Abstract: Single-cell RNA sequencing (scRNA-seq) data exhibit strong and reproducible statistical structure. This has motivated the development of large-scale foundation models, such as TranscriptFormer, that use transformer-based architectures to learn a generative model for gen‚Ä¶

- **[The lingering phenomenon and pattern formation in a nonlocal population model with cognitive map](https://arxiv.org/abs/2602.16022)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16022v1 Announce Type: cross 
Abstract: The rates at which individuals memorize and forget environmental information strongly influence their movement paths and long-term space use. To understand how these cognitive time scales shape population-level patterns, we propose and analyze a nonlocal population mo‚Ä¶

- **[Omni-iEEG: A Large-Scale, Comprehensive iEEG Dataset and Benchmark for Epilepsy Research](https://arxiv.org/abs/2602.16072)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16072v1 Announce Type: cross 
Abstract: Epilepsy affects over 50 million people worldwide, and one-third of patients suffer drug-resistant seizures where surgery offers the best chance of seizure freedom. Accurate localization of the epileptogenic zone (EZ) relies on intracranial EEG (iEEG). Clinical workfl‚Ä¶

- **[Optical Inversion and Spectral Unmixing of Spectroscopic Photoacoustic Images with Physics-Informed Neural Networks](https://arxiv.org/abs/2602.16357)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16357v1 Announce Type: cross 
Abstract: Accurate estimation of the relative concentrations of chromophores in a spectroscopic photoacoustic (sPA) image can reveal immense structural, functional, and molecular information about physiological processes. However, due to nonlinearities and ill-posedness inheren‚Ä¶

- **[A Systematic Evaluation of Sample-Level Tokenization Strategies for MEG Foundation Models](https://arxiv.org/abs/2602.16626)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2602.16626v1 Announce Type: cross 
Abstract: Recent success in natural language processing has motivated growing interest in large-scale foundation models for neuroimaging data. Such models often require discretization of continuous neural time series data, a process referred to as 'tokenization'. However, the i‚Ä¶

- **[Pore-level Quantitative Structure-Activity Relationship (QSAR) for Water Permeation Rate in Aquaporins](https://arxiv.org/abs/2410.14355)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2410.14355v2 Announce Type: replace 
Abstract: Aquaporins (AQPs) and aquaglyceroporins (AQGPs) play a crucial role in regulating water transport and solute selectivity across biological membranes. Besides their biological relevance, AQPs have at-tracted growing interest as models for the design of next-generatio‚Ä¶

- **[Weight transport through spike timing for robust local gradients](https://arxiv.org/abs/2503.02642)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2503.02642v2 Announce Type: replace 
Abstract: In both machine learning and in computational neuroscience, plasticity in functional neural networks is frequently expressed as gradient descent on a cost. Often, this imposes symmetry constraints that are difficult to reconcile with local computation, as is require‚Ä¶

- **[Likelihood-free inference of phylogenetic tree posterior distributions](https://arxiv.org/abs/2510.12976)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2510.12976v3 Announce Type: replace 
Abstract: Phylogenetic inference, the task of reconstructing how related sequences evolved from common ancestors, is a central objective in evolutionary genomics. The current state-of-the-art methods exploit probabilistic models of sequence evolution along phylogenetic trees,‚Ä¶

- **[GENESIS: A Generative Model of Episodic-Semantic Interaction](https://arxiv.org/abs/2510.15828)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2510.15828v2 Announce Type: replace 
Abstract: A central challenge in cognitive neuroscience is to explain how semantic and episodic memory, two major forms of declarative memory, typically associated with cortical and hippocampal processing, interact to support learning, recall, and imagination. Despite signifi‚Ä¶

- **[Large-sample analysis of cost functionals for inference under the coalescent](https://arxiv.org/abs/2412.06004)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2412.06004v2 Announce Type: replace-cross 
Abstract: The coalescent is a foundational model of latent genealogical trees under neutral evolution, but suffers from intractable sampling probabilities. Methods for approximating these sampling probabilities either introduce bias or fail to scale to large sample size‚Ä¶

- **[Integrating Chain-of-Thought and Retrieval Augmented Generation Enhances Rare Disease Diagnosis from Clinical Notes](https://arxiv.org/abs/2503.12286)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2503.12286v2 Announce Type: replace-cross 
Abstract: Background: Several studies show that large language models (LLMs) struggle with phenotype-driven gene prioritization for rare diseases. These studies typically use Human Phenotype Ontology (HPO) terms to prompt foundation models like GPT and LLaMA to predict‚Ä¶

- **[Nonequilibrium Theory for Adaptive Systems in Varying Environments](https://arxiv.org/abs/2506.19018)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2506.19018v2 Announce Type: replace-cross 
Abstract: Biological organisms are adaptive, able to function in unpredictably changing environments. Drawing on recent nonequilibrium physics, we show that in adaptation, fitness has two components parameterized by observable coordinates: a static Generalism component‚Ä¶

- **[Threshold sensing yields optimal path formation in Physarum polycephalum](https://arxiv.org/abs/2507.12347)**  
  _Thu, 19 Feb 2026 00:00:00 -0500_  
  arXiv:2507.12347v2 Announce Type: replace-cross 
Abstract: The model organism Physarum polycephalum is known to perform decentralised problem solving despite absence of nervous system. Experimental evidence and modelling studies have linked these abilities, and in particular maze-solving, to some sort of memory and ad‚Ä¶
